| IPAD-DB ID | C01100 |
| Name | Naringin |
| Category | Natural compounds |
| 2D Structure |
|
| 3D Structure | |
| Molecular Formula | C 2 7 H 3 2 O 1 4 |
| Molecular Weight | 580.5g/mol |
| IUPAC Name | (2S)-7-[(2S, 3R, 4S, 5S, 6R)-4, 5-dihydroxy-6-(hydroxymethyl)-3-[(2S, 3R, 4R, 5R, 6S)-3, 4, 5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2, 3-dihydrochromen-4-one |
| InChI | InChI=1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7, 10, 16, 18, 20-30, 32-36H, 8-9H2, 1H3/t10-, 16-, 18+, 20-, 21+, 22+, 23-, 24+, 25+, 26-, 27+/m0/s1 |
| InChIKey | DFPMSGMNTNDNHN-ZPHOTFPESA-N |
| Canonical SMILES | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O |
| PubChem CID | 442428 |
| DrugBank Accession Number | - |
| CAS Registry Number | 10236-47-2 |
| Molecular Weight(Computed by SwissADME) | 580.53 |
| Hac(Computed by SwissADME) | 41 |
| Volume(Computed by ADMETlab 2.0) | 537.374 |
| Density(Computed by ADMETlab 2.0) | 1.08 |
| nRing(Computed by ADMETlab 2.0) | 5 |
| MaxRing(Computed by ADMETlab 2.0) | 10 |
| nHet(Computed by ADMETlab 2.0) | 14 |
| fChar(Computed by ADMETlab 2.0) | 0 |
| nRig(Computed by ADMETlab 2.0) | 30 |
| Flexibility(Computed by ADMETlab 2.0) | 0.2 |
| Stero Centers(Computed by ADMETlab 2.0) | 11 |
| LogS(Computed by ADMETlab 2.0) | -3.43 |
| LogD(Computed by ADMETlab 2.0) | 1.065 |
| logP(Computed by ADMETlab 2.0) | -1.17 |
| TPSA(Computed by SwissADME) | 225.06 Ų |
| Hbond Acceptor(Computed by SwissADME) | 14 |
| Hbond Donor(Computed by SwissADME) | 8 |
| Rotatable Bonds(Computed by SwissADME) | 6 |
| GI Absorption(Computed by SwissADME) | Low |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
| P-gp Substrate(Computed by SwissADME) | Yes |
| CYP1A2 Inhibitor(Computed by SwissADME) | No |
| CYP2C19 Inhibitor(Computed by SwissADME) | No |
| CYP2C9 Inhibitor(Computed by SwissADME) | No |
| CYP2D6 Inhibitor(Computed by SwissADME) | No |
| CYP3A4 Inhibitor(Computed by SwissADME) | No |
| log Kp(Skin Permeation)(Computed by SwissADME) | -10.15 cm/s |
| Lipinski(Computed by SwissADME) | No, 3 violations: MW>500, NorO>10, NHorOH>5 |
| Ghose(Computed by SwissADME) | No, 4 violations: MW>480, WLOGP<-0.4, MR>130, #atoms>70 |
| Veber(Computed by SwissADME) | No, 1 violation: TPSA>140 |
| Egan(Computed by SwissADME) | No, 1 violation: TPSA>131.6 |
| Muegge(Computed by SwissADME) | No, 3 violations: TPSA>150, H-acc>10, H-don>5 |
| Bioavailability Score(Computed by SwissADME) | 0.17 |